STREPTOCOCCUS AGALACTIAE GENOME SEQUENCE, USE FOR DEVELOPING VACCINES, DIAGNOSTIC TOOLS, AND FOR IDENTIFYING THERAPEUTIC TARGETS

Details for Australian Patent Application No. 2002319867 (hide)

Owner INSTITUT PASTEUR CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS)

Inventors CHEVALIER, Fabien; RUSNIOK, Christophe; GLASER, Philippe; KUNST, Frank; TRIEU-CUOT, Patrick; POYART, Claire; BUCHRIESER, Carmen; COUVE, Elisabeth; ZOUINE, Mohamed; LALIOUI, Lila; FRANGEUL, Lionel

Pub. Number AU-A-2002319867

PCT Number PCT/IB02/03059

PCT Pub. Number WO2002/092818

Priority 2001/05642 26.04.01 FR

Filing date 26 April 2002

Wipo publication date 25 November 2002

International Classifications

C07K 016/12 Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from bacteria

C12Q 001/68 Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

A61K 048/00 Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61K 039/09 Medicinal preparations containing antigens or antibodies - Streptococcus

C07K 014/315 Peptides having more than 20 amino acids

C12N 001/21 Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 001/20 Micro-organisms, e.g. protozoa - Bacteria

C12N 005/10 Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 015/74 Mutation or genetic engineering - Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora

C12N 015/62 Mutation or genetic engineering - DNA sequences coding for fusion proteins

A61P 031/04 Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61K 039/395 Medicinal preparations containing antigens or antibodies - Antibodies

G01N 033/53 Investigating or analysing materials by specific methods not covered by groups - Immunoassay

C07K 019/00 Hybrid peptides

C12N 015/31 Mutation or genetic engineering - Genes encoding microbial proteins, e.g. enterotoxins

Event Publications

16 January 2003 Complete Application Filed

  Priority application(s): 2001/05642 26.04.01 FR

1 May 2003 Application Open to Public Inspection

  Published as AU-A-2002319867

19 February 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002319868-GENE EXPRESSION DURING MENINGOCOCCUS ADHESION

2002319866-AN IMPROVED PROCESS FOR THE RECOVERY OF SULPHUR FROM GASES CONTAINING HYDROGEN SULPHIDE